ch
Feedback
Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️

Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️

前往频道在 Telegram

Join this group if you are preparing for life science and biotechnology exams. No sharing of other coaching's copyrighted material. No spam No promotion No personal message to any member No irrelevant discussion No irrelevant post

显示更多

📈 Telegram 频道 Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️ 的分析概览

频道 Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️ (@smartlearningacademy) 英语 语言赛道中的 是活跃参与者。目前社区聚集了 18 508 名订阅者,在 教育 类别中位列第 10 898,并在 印度 地区排名第 23 655

📊 受众指标与增长动态

невідомо 创建以来,项目保持高速增长,吸引了 18 508 名订阅者。

根据 17 六月, 2026 的最新数据,频道保持稳定运转。过去 30 天订阅人数变化为 235,过去 24 小时变化为 -4,整体触达仍然可观。

  • 认证状态: 未认证
  • 互动率 (ER): 平均受众互动率为 12.76%。内容发布后 24 小时内通常能获得 6.92% 的反应,占订阅者总量。
  • 帖子覆盖: 每篇帖子平均可获得 2 362 次浏览,首日通常累积 1 281 次浏览。
  • 互动与反馈: 受众积极参与,单帖平均反应数为 3
  • 主题关注点: 内容集中在 vedemy, nat, revision, calculation, rahe 等核心主题上。

📝 描述与内容策略

作者将该频道定位为表达主观观点的平台:
Join this group if you are preparing for life science and biotechnology exams. No sharing of other coaching's copyrighted material. No spam No promotion No personal message to any member No irrelevant discussion No irrelevant post

凭借高频更新(最新数据采集于 18 六月, 2026),频道始终保持新鲜度与高覆盖。分析显示受众积极互动,使其成为 教育 类别中的关键影响点。

18 508
订阅者
-424 小时
+787
+23530
帖子存档
🚨 Microbiology Job Opportunity – Apply Now! 🚨 Subscribe FREE for More job alerts: https://www.vedemy.com/feeds 🧫 Teva Pharmaceutical Industries is hiring for a Quality Control (QC) role for Microbiology & Life Sciences candidates. If you want to build your career in QC Microbiology, pharmaceutical testing, GMP labs, and regulatory compliance, this is a great opportunity to work with one of the world’s leading pharmaceutical companies. 👉 Microbiology / Biotechnology / Life Sciences candidates are encouraged to apply. 📌 Check eligibility details and apply before the deadline. 📱: https://www.youtube.com/@vedemy 📱: https://www.instagram.com/vedemy_educating_india/?hl=en 📢 Perfect opportunity for students aiming for a career in the pharmaceutical industry!

🚨 Biotech + AI Breakthrough – Must Know for Exams! 🚨 Subscribe FREE for More job alerts: https://www.vedemy.com/feeds 🧬 What if your “normal” health reports are actually hiding a serious risk? New research shows that AI + CRISPR technology can detect hidden heart disease risks even when routine tests look normal! 👉 Scientists are using Artificial Intelligence to analyze complex biological data and CRISPR to study or even correct faulty genes linked to heart conditions. 📌 Key concepts to revise: AI in healthcare, CRISPR gene editing, genetic disorders, biomarkers, precision medicine 📱: https://www.youtube.com/@vedemy 📱: https://www.instagram.com/vedemy_educating_india/?hl=en 📢 Remember: Future medicine is shifting from treatment → prevention!

🚨 Research Job Opportunity for Life Science Students – Apply Now! 🚨 Subscribe FREE for More job alerts: https://www.vedemy.com/feeds 🧪 Vitely Bio is hiring Life Sciences candidates for Research Associate positions. If you are looking to build a career in microbiology, analytical research, pharmaceutical testing, or CRO-based industry roles, this is a great opportunity to gain real lab experience in a professional research environment. Life Sciences / Biotechnology / Microbiology candidates are encouraged to apply. 📌 Check eligibility and apply before the deadline. 📱: https://www.youtube.com/@vedemy 📱: https://www.instagram.com/vedemy_educating_india/?hl=en 📢 Perfect opportunity to start your research career in industry!

Plant Physiology will be continued from 11th May

🚨 Big Breakthrough in Biotechnology – Must Know for Exams! 🚨 Subscribe FREE for More job alerts: https://www.vedemy.com/feeds 🧬 The world’s first gene therapy for deafness has received approval from the U.S. Food and Drug Administration (FDA) — marking a historic milestone in medical science. 📱: https://www.youtube.com/@vedemy 📱: https://www.instagram.com/vedemy_educating_india/?hl=en This therapy works by correcting the defective gene responsible for hearing loss, opening new possibilities for treating genetic disorders at their root cause rather than just managing symptoms.

Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️ - Telegram 频道 @smartlearningacademy 的统计与分析